UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021501
Receipt number R000024797
Scientific Title Clinical study of photodynamic therapy for peripheral typelung cancers
Date of disclosure of the study information 2016/03/16
Last modified on 2018/03/18 11:09:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of photodynamic therapy for peripheral typelung cancers

Acronym

Clinical study of photodynamic therapy for peripheral typelung cancers

Scientific Title

Clinical study of photodynamic therapy for peripheral typelung cancers

Scientific Title:Acronym

Clinical study of photodynamic therapy for peripheral typelung cancers

Region

Japan


Condition

Condition

Lung Cancer

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To study the safety and efficacy of Photodynamic therapy for periferal lung cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

frequency of adverse event of grade 2 or more within 90 days of PDT

Key secondary outcomes

Recurrence free survival rate at 90days and 1 year after PDT


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Photodynamic theapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cancer nodule within 20mm in maximum measured by thin-slice CT
Negative for lymphnode or distant metastasis measured by FDG-PET, abdomnal CT or US, Brain CT or MRI.
ECOG PS 0-2
Over 20 years old
Platete: 100000~400000
PT-INR: less than 1.4
Diagnosed as non-small cell lung cancer by trans-bronchal biopsy or cytology
Inoperable case or Reject operation cases
with written informed concent

Key exclusion criteria

Patients with anti-coagulant dose, except for salicylic acid formulation in the past week
women who are/may pregnant, or lactating
Patients with serious complications such as heart disease, liver disease and kidney failure
Patients who have the porphyria
Patients who have the sunlight hypersensitivity
Patients who have been determined to be inappropriate as a subject upon the doctor's discretion

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jitsuo Usuda

Organization

Nippon Medical School Hospital

Division name

Thoracic Surgery

Zip code


Address

1 Chome-1-5 Sendagi Bunkyo-ku, Tokyo

TEL

03-3822-2131

Email

jusuda@nms.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Jitsuo Usuda

Organization

Nippon Medical School Hospital

Division name

Thoracic Surgery

Zip code


Address

1 Chome-1-5 Sendagi Bunkyo-ku, Tokyo

TEL

03-3822-2131

Homepage URL


Email

jusuda@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 17 Day

Date of IRB


Anticipated trial start date

2016 Year 03 Month 16 Day

Last follow-up date

2018 Year 04 Month 30 Day

Date of closure to data entry

2018 Year 04 Month 30 Day

Date trial data considered complete


Date analysis concluded

2018 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 03 Month 16 Day

Last modified on

2018 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024797


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name